CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
15 Oct, 08:00 PM
NYSE NYSE
$
92. 58
+2.19
+2.4228%
$
112.03B Market Cap
11.4 P/E Ratio
0.64% Div Yield
14.26M Volume
7.87 Eps
$ 90.39
Previous Close
Add Transaction
Day Range
91 92.64
Year Range
69.51 110.68
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why CVS Health (CVS) is a Strong Momentum Stock

Here's Why CVS Health (CVS) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 3 months ago
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Zacks | 3 months ago
Are You Looking for a Top Momentum Pick? Why CVS Health (CVS) is a Great Choice

Are You Looking for a Top Momentum Pick? Why CVS Health (CVS) is a Great Choice

Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 3 months ago
CVS Health: The Surprising Healthcare Outlier

CVS Health: The Surprising Healthcare Outlier

CVS Health Corporation has outperformed peers, overcoming industry headwinds through effective management and strategic execution. CVS delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low-double-digit investor returns. While Health Services and Insurance segments anticipate mid-single-digit growth, retail is set for gradual decline but with margin improvements.

Seekingalpha | 3 months ago
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 3 months ago
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run?

CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run?

CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 3 months ago
Magic Formula Showdown: Why CVS Beats Qualcomm and Valero for Retirees

Magic Formula Showdown: Why CVS Beats Qualcomm and Valero for Retirees

Joel Greenblatt's Magic Formula, popularized in The Little Book That Beats the Market, ranks stocks on two factors: earnings yield (operating earnings divided by enterprise value) and return on capital (how efficiently a business converts invested dollars into profits).

247wallst | 3 months ago
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 3 months ago
CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?

CVS Health (CVS) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 3 months ago
Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term

Why CVS Health (CVS) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 3 months ago
CVS Health (CVS) is a Great Momentum Stock: Should You Buy?

CVS Health (CVS) is a Great Momentum Stock: Should You Buy?

Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks | 3 months ago
5 Low Price-to-Book Stocks That Are Worth Buying in June

5 Low Price-to-Book Stocks That Are Worth Buying in June

STNE, USNA, STRA, NEXA and CVS passed a low price-to-book screen, combining discounted valuations with projected long-term EPS growth.

Zacks | 4 months ago
Loading...
Load More